Colorectal Carcinoma
|
0.340 |
Biomarker
|
disease |
BEFREE |
Nuclear orphan receptor NR4A2 modulates fatty acid oxidation pathways in colorectal cancer.
|
21757690 |
2011 |
Colorectal Carcinoma
|
0.340 |
Biomarker
|
disease |
BEFREE |
Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
|
19549529 |
2009 |
Bipolar Disorder
|
0.340 |
Biomarker
|
disease |
PSYGENET |
These data show a deficient prefrontal NGFI-B and Nurr1 expression in schizophrenia and bipolar disorder.
|
16631355 |
2006 |
Bipolar Disorder
|
0.340 |
AlteredExpression
|
disease |
BEFREE |
These data show a deficient prefrontal NGFI-B and Nurr1 expression in schizophrenia and bipolar disorder.
|
16631355 |
2006 |
Colorectal Carcinoma
|
0.340 |
Biomarker
|
disease |
CTD_human |
Human colorectal cancers relative to matched normal mucosa showed increased NR4A2 expression.
|
16293616 |
2006 |
Colorectal Carcinoma
|
0.340 |
AlteredExpression
|
disease |
BEFREE |
Human colorectal cancers relative to matched normal mucosa showed increased NR4A2 expression.
|
16293616 |
2006 |
Bipolar Disorder
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
To test the hypothesis that genetic variants of the retinoid receptor genes may predispose to schizophrenia and other psychiatric diseases, the six RAR and RXR genes and a heterodimer partner, the NURR1 gene, were scanned in 100 schizophrenia patients, along with pilot studies in 20-24 patients with bipolar disorder (BPD), attention-deficit hyperactivity disorder (ADHD), autism, or alcoholism.
|
15635645 |
2005 |
Bipolar Disorder
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
Evidence by others support this hypothesis (1) mapping of the NR4A2 gene to chromosome 2q22-23, a region with suggestive linkage to schizophrenia and (2) identification of mutations in patients with schizophrenia (c.366-369delTAC, c.308A > G, c.-469delG), manic depression (c.289A > G), and familial Parkinson's disease (c.-291delT, c.-245T > G).
|
15211629 |
2004 |
Bipolar Disorder
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
NURR1 mutations in cases of schizophrenia and manic-depressive disorder.
|
11121187 |
2000 |
Alcoholic Intoxication, Chronic
|
0.330 |
Biomarker
|
disease |
PSYGENET |
Polymorphisms in the regulatory region of Nurr1 are implicated in pathogenesis of alcohol dependence and the Nurr1/dopamine signaling pathway might be important for this dependence development in Mexican Americans.
|
23066323 |
2012 |
Alcoholic Intoxication, Chronic
|
0.330 |
Biomarker
|
disease |
BEFREE |
Polymorphisms in the regulatory region of Nurr1 are implicated in pathogenesis of alcohol dependence and the Nurr1/dopamine signaling pathway might be important for this dependence development in Mexican Americans.
|
23066323 |
2012 |
Alcoholic Intoxication, Chronic
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
To test the hypothesis that genetic variants of the retinoid receptor genes may predispose to schizophrenia and other psychiatric diseases, the six RAR and RXR genes and a heterodimer partner, the NURR1 gene, were scanned in 100 schizophrenia patients, along with pilot studies in 20-24 patients with bipolar disorder (BPD), attention-deficit hyperactivity disorder (ADHD), autism, or alcoholism.
|
15635645 |
2005 |
Alcoholic Intoxication, Chronic
|
0.330 |
Biomarker
|
disease |
LHGDN |
However, they revealed a significant association between the NR4A2 gene haplotype and alcohol dependence, indicating that 2q22-q23 including the NR4A2 gene locus is a possible genomic region contributing to genetic susceptibility to alcohol dependence.
|
11840500 |
2002 |
Alcoholic Intoxication, Chronic
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
However, they revealed a significant association between the NR4A2 gene haplotype and alcohol dependence, indicating that 2q22-q23 including the NR4A2 gene locus is a possible genomic region contributing to genetic susceptibility to alcohol dependence.
|
11840500 |
2002 |
PARKINSON DISEASE, LATE-ONSET
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
However, NURR1 (57.631% reduced in males; 28.93% in females) and FOXA1 (64.42% in males; 55.76% in females) mRNA expression did differ greatly between male and female PD patients.
|
28255498 |
2017 |
Arthritis, Psoriatic
|
0.320 |
Biomarker
|
disease |
CTD_human |
Identification of NR4A2 as a transcriptional activator of IL-8 expression in human inflammatory arthritis.
|
19732956 |
2009 |
PARKINSON DISEASE, LATE-ONSET
|
0.320 |
Biomarker
|
disease |
BEFREE |
We performed a mutation screen of NR4A2 (also known as NURR1) in 409 Parkinson's disease (PD) patients.
|
19429166 |
2009 |
Arthritis, Psoriatic
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
MTX significantly suppresses expression of NURR1 in vivo in patients with active psoriatic arthritis (n = 10; p < 0.002) who were prescribed low-dose MTX for management of peripheral arthritis.
|
15972692 |
2005 |
Arthritis, Psoriatic
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
NURR1 was abundantly expressed in the inflammatory cells of both RA and PsA synovium.
|
11315917 |
2001 |
PARKINSON DISEASE, LATE-ONSET
|
0.320 |
Biomarker
|
disease |
CTD_human |
|
|
|
Intellectual Disability
|
0.310 |
Biomarker
|
group |
BEFREE |
NR4A2 haploinsufficiency is associated with intellectual disability and autism spectrum disorder.
|
29770430 |
2018 |
Language Disorders
|
0.310 |
Biomarker
|
group |
BEFREE |
Our findings of a de novo deletion of NR4A2 in an individual with mild intellectual disability and prominent speech and language impairment provides further evidence for NR4A2 haploinsufficiency being causative for neurodevelopmental and particularly language phenotypes.
|
28544326 |
2017 |
Colorectal Neoplasms
|
0.310 |
Biomarker
|
group |
CTD_human |
Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer.
|
16293616 |
2006 |
Colorectal Neoplasms
|
0.310 |
Biomarker
|
group |
LHGDN |
Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer.
|
16293616 |
2006 |
Unipolar Depression
|
0.310 |
Biomarker
|
disease |
BEFREE |
Nurr1 protein in BA 9 was significantly lower in major depression (P<0.05) and lower at a trend level in schizophrenia (P=0.056) than in the controls.
|
16631355 |
2006 |